SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-035480
Filing Date
2024-03-22
Accepted
2024-03-22 17:12:53
Documents
99
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sctl-20231231.htm   iXBRL 10-K 2262916
2 EX-3.3 sctl-ex3_3.htm EX-3.3 13830
3 EX-4.4 sctl-ex4_4.htm EX-4.4 30563
4 EX-10.28 sctl-ex10_28.htm EX-10.28 1585590
5 EX-21.1 sctl-ex21_1.htm EX-21.1 7735
6 EX-23.1 sctl-ex23_1.htm EX-23.1 2470
7 EX-31.1 sctl-ex31_1.htm EX-31.1 12596
8 EX-31.2 sctl-ex31_2.htm EX-31.2 12574
9 EX-32.1 sctl-ex32_1.htm EX-32.1 7865
10 EX-97.1 sctl-ex97_1.htm EX-97.1 34559
  Complete submission text file 0000950170-24-035480.txt   12377769

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sctl-20231231.xsd EX-101.SCH 1851695
103 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20231231_htm.xml XML 1559071
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36329 | Film No.: 24776174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)